Warren Buffett’s 3 Worst Performing Stock Picks From 2021

2. Teva Pharmaceutical Industries Limited (NYSE:TEVA)

Berkshire Hathaway’s Stake Value: $416,768,000

Percentage of Berkshire Hathaway’s 13F Portfolio: 0.14%

Number of Hedge Fund Holders: 22

Loss in 2021: 23.59%

Teva Pharmaceutical Industries Limited (NYSE:TEVA) is an Israeli multinational pharmaceutical company that manufactures generic drugs and biopharmaceutical medicines. Teva Pharmaceutical Industries Limited (NYSE:TEVA) returned a loss of 23.59% in 2021, thus making it to our list of Warren Buffett’s worst performing stock picks. The company also failed to meet its Q3 2021 EPS and revenue consensus estimates. 

Acquiring a stake in Teva Pharmaceutical Industries Limited (NYSE:TEVA) back in Q4 2017, Buffett’s position in the stock has remained unchanged since the first quarter of 2020. He holds 42.78 million Teva Pharmaceutical Industries Limited (NYSE:TEVA) shares, worth $416.7 million in Q3 2021, representing 0.14% of the billionaire’s total 13F securities. 

Teva Pharmaceutical Industries Limited (NYSE:TEVA)’s shares fell 4.7% on December 30, 2021, when the New York court charged the company as guilty of fueling the opioid crisis. Teva Pharmaceutical Industries Limited (NYSE:TEVA) disagrees with this conviction and will pursue a mistrial. 

Among the hedge funds tracked by Insider Monkey in the third quarter of 2021, 22 funds reported owning stakes in Teva Pharmaceutical Industries Limited (NYSE:TEVA), worth $950.6 million. David Abrams’ Abrams Capital Management is one of the leading company stakeholders, holding 24 million shares, valued at $234.2 million.